Growth Metrics

Integra Lifesciences Holdings (IART) Non-Current Deferred Tax Liability (2016 - 2026)

Integra Lifesciences Holdings' Non-Current Deferred Tax Liability history spans 17 years, with the latest figure at $5.7 million for Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 97.85% to $5.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.7 million, a 97.85% decrease, with the full-year FY2025 number at $5.7 million, down 97.85% from a year prior.
  • Non-Current Deferred Tax Liability hit $5.7 million in Q4 2025 for Integra Lifesciences Holdings, down from $58.3 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for IART hit a ceiling of $263.4 million in Q4 2024 and a floor of $5.7 million in Q4 2025.
  • Historically, Non-Current Deferred Tax Liability has averaged $82.4 million across 5 years, with a median of $64.4 million in 2021.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: soared 924.31% in 2021 and later tumbled 97.85% in 2025.
  • Tracing IART's Non-Current Deferred Tax Liability over 5 years: stood at $169.8 million in 2021, then increased by 28.56% to $218.3 million in 2022, then crashed by 83.82% to $35.3 million in 2023, then soared by 645.79% to $263.4 million in 2024, then tumbled by 97.85% to $5.7 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for IART at $5.7 million in Q4 2025, $58.3 million in Q3 2025, and $60.1 million in Q2 2025.